Related Experiment Video
Updated: Jun 5, 2025

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
3.6K
Selective Deep-Lobe Parotidectomy for Benign Parotid Gland Tumors.
A Bayram1, A Ş Genç1, S Altıparmak1
1Department of ENT, Kayseri City Training and Research Hospital, Kayseri, Turkey.
Nigerian Journal of Clinical Practice
|December 3, 2024
Summary
Selective deep-lobe parotidectomy (SDLP) offers a safe and effective approach for benign parotid tumors. This method demonstrates reduced complications and excellent cosmetic results, ensuring oncological safety.
Area of Science:
- Otolaryngology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Deep-lobe parotid tumors have thicker capsules and less penetration than superficial tumors.
- Conservative surgical approaches are often favored for benign deep-lobe parotid gland tumors.
Purpose of the Study:
- To evaluate the surgical outcomes and oncological safety of selective deep-lobe parotidectomy (SDLP).
- To assess complication rates and cosmetic results following SDLP for benign deep-lobe parotid lesions.
Main Methods:
- Retrospective evaluation of 22 patients who underwent SDLP.
- Data collected included patient demographics, tumor characteristics, hospitalization, recurrence, complications (e.g., facial nerve impairment, Frey's syndrome), and cosmetic outcomes.
- Facial contour symmetry was assessed using a 0-10 visual analog scale (VAS) post-surgery.
Main Results:
- Pleomorphic adenoma was the most common diagnosis (59.1%).
- Temporary facial nerve (FN) paralysis occurred in 13% of patients, resolving spontaneously.
- No permanent FN paralysis, Frey's syndrome, first-bite syndrome, or sialocele were observed. Mean VAS score for symmetry was 9.43.
- Median follow-up was 71.7 months with no recurrences.
Conclusions:
- SDLP is a safe surgical option for benign deep-lobe parotid gland lesions.
- The procedure is associated with low complication rates and favorable cosmetic outcomes.
- Oncological safety is maintained with SDLP for these tumors.

